Published in Curr Neurovasc Res on January 01, 2015
Atrial Fibrillation in the Young: A Neurologist's Nightmare. Neurol Res Int (2015) 0.75
Management of intracerebral hemorrhage-use of statins. Vasc Health Risk Manag (2016) 0.75
Subarachnoid Haemorrhage and Sports. Cerebrovasc Dis Extra (2015) 0.75
Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science (2009) 8.76
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature (2011) 4.58
Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron (2006) 4.39
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci (2010) 3.47
Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron (2012) 2.91
Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons. Science (2008) 2.82
Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron (2003) 2.81
A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell (2003) 2.72
Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron (2008) 2.69
Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci (2004) 2.59
Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature (2008) 2.47
Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron (2008) 2.41
Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci (2011) 2.37
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci (2004) 2.33
Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens. Nat Neurosci (2006) 2.23
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci (2003) 2.21
Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature (2013) 2.15
Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci (2008) 2.15
Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci (2009) 2.02
Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) (2008) 1.89
Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat Neurosci (2012) 1.79
Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biol Psychiatry (2010) 1.74
Synaptic plasticity and drug addiction. Curr Opin Pharmacol (2005) 1.73
Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol (2008) 1.71
AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron (2010) 1.68
Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J Neurosci (2002) 1.66
Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci (2006) 1.63
Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. J Neurophysiol (2004) 1.62
NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1. Proc Natl Acad Sci U S A (2002) 1.59
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A (2005) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci (2011) 1.46
The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol (2005) 1.45
Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. Proc Natl Acad Sci U S A (2008) 1.41
Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci (2003) 1.38
Endocytosis promotes rapid dopaminergic signaling. Neuron (2011) 1.35
Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake. Nat Neurosci (2013) 1.35
Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. Eur J Neurosci (2007) 1.33
C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. Science (2013) 1.31
Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell (2013) 1.31
Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro. J Neurophysiol (2007) 1.30
The melanin-concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A (2009) 1.30
Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci (2014) 1.30
Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci (2012) 1.29
Voluntary ethanol intake enhances excitatory synaptic strength in the ventral tegmental area. Alcohol Clin Exp Res (2008) 1.29
Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Ann N Y Acad Sci (2010) 1.28
Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence. Neuron (2010) 1.27
Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J Neurosci (2013) 1.26
Motivation for alcohol becomes resistant to quinine adulteration after 3 to 4 months of intermittent alcohol self-administration. Alcohol Clin Exp Res (2010) 1.23
The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci (2012) 1.22
Effects of stress and aversion on dopamine neurons: implications for addiction. Neurosci Biobehav Rev (2010) 1.21
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. J Biol Chem (2005) 1.18
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology (2004) 1.13
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis (2007) 1.12
Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci (2009) 1.11
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Transient activation of specific neurons in mice by selective expression of the capsaicin receptor. Nat Commun (2012) 1.10
CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat Neurosci (2013) 1.09
Optogenetic modulation of neural circuits that underlie reward seeking. Biol Psychiatry (2011) 1.09
Methylphenidate facilitates learning-induced amygdala plasticity. Nat Neurosci (2010) 1.09
Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci (2010) 1.08
Sizing up ethanol-induced plasticity: the role of small and large conductance calcium-activated potassium channels. Alcohol Clin Exp Res (2009) 1.08
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir Med (2008) 1.07
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Mitogen-activated protein kinases and asthma. J Cell Physiol (2005) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke (2009) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) (2013) 1.02
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Neural estimates of imagined outcomes in the orbitofrontal cortex drive behavior and learning. Neuron (2013) 1.01
Context-induced relapse to alcohol seeking after punishment in a rat model. Biol Psychiatry (2012) 1.01
Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Res (2009) 1.01
Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci (2009) 1.00
Neuroplastic alterations in the limbic system following cocaine or alcohol exposure. Curr Top Behav Neurosci (2010) 1.00
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci (2003) 0.98
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. Neuroreport (2002) 0.98
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. Neuropsychopharmacology (2011) 0.97
Rapid constitutive and ligand-activated endocytic trafficking of P2X receptor. J Neurochem (2009) 0.97
Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen (2013) 0.97
Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur J Neurosci (2005) 0.97
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res (2013) 0.96
High prevalence of patent foramen ovale in migraine with aura. J Headache Pain (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
The role of acetaldehyde in the central effects of ethanol. Alcohol Clin Exp Res (2005) 0.95